Bicara Therapeutics Inc. (BCAX) Insider Trading

Name: Bicara Therapeutics Inc. (BCAX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 10, 2026): Cohlhepp Ryan (President, COO & Interim CEO): Exercise/Conversion of 17,500 shares, $66.3K.

Get alerted when insiders trade BCAX

Email address

Loading company data...

Loading company details...